Alternative treatments for adults with attention-deficit hyperactivity disorder (ADHD)

Annals of the New York Academy of Sciences

Volumn 931, Issue , 2001, Pages 310-341

  Eugene Arnold, L ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

ADHD; Adult; Alternative treatment; Attention deficit; Biofeedback; Diet; Herbal; Hyperactivity; Lead; Massage; Nutrition; Sensory perceptual; Thyroid; Treatment; Yeast

Indexed keywords

AMINO ACID; ANTIFUNGAL AGENT; ANTITHYROID AGENT; ESSENTIAL FATTY ACID; IRON; MAGNESIUM; VITAMIN; ZINC;

ACUPUNCTURE; ADULT; ALTERNATIVE MEDICINE; ATTENTION DEFICIT DISORDER; CHINESE HERB; CHINESE MEDICINE; DESENSITIZATION; DIET THERAPY; DRUG MEGADOSE; ELECTROENCEPHALOGRAM; ELECTROMYOGRAM; FEEDBACK SYSTEM; HOMEOPATHY; HUMAN; IRON THERAPY; LASER; MASSAGE; MEDICAL LITERATURE; MEDITATION; NUTRITION; PERCEPTION; RELAXATION TRAINING; REVIEW; THYROID DISEASE; TREATMENT INDICATION; VESTIBULAR STIMULATION;

EID: 0034952028     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2001.tb05788.x     Document Type: Review

References (186)

1. Treatment alternatives for attention-deficit/hyperactivity disorder (ADHD)
2. Treatment alternatives for attention-deficit/hyperactivity disorder (ADHD)
3. NIH Consensus Development Conference: Defined diets and childhood hyperactivity
4. Food dyes and impairment of performance in hyperactive children
5. Diet in the management of hyperkinesis
6. The Feingold diet: A current reappraisal
7. Hyperactivity and diet treatment: A meta-analysis of the Feingold hypothesis
8. Refutes criticism of diet [reply to nutrition foundation report]
9. The Feingold diet: An assessment of the reviews by Mattes, by Kavale and Forness, and others
10. Food additives and hyperactive children: A critique of Conners
11. The role of diet and behavior in childhood
12. Dietary replacement in preschool-aged hyperactive boys
13. Does oligoantigenic diet influence hyperactive/conduct-disordered children - A controlled trial
14. Controlled trial of oligoantigenic treatment in the hyperkinetic syndrome
15. Controlled trial of hyposensitization in children with food-induced hyperkinetic syndrome
16. Effect of artificial food colors on childhood behavior
17. Effects of a few-food diet in attention deficit disorder
18. Synthetic food coloring and behavior: A dose-response effect in a double-blind, placebo-controlled, repeated-measures study
19. Foods and additives are common causes of the attention deficit hyperactive disorder in children
20. Trace mineral levels in hyperactive children responding to the Feingold diet
21. Synthetic food colorings and hyperactivity: A double-blind crossover study
22. Hyperactivity: Is candy causal?
23. The effect of sugar on behavior or cognition in children
24. Behavioral effects of sucrose on preschool children
25. Effects of diets high in sucrose or aspartame on the behavior and cognitive performance of children
26. Seven-day carbohydrate and other nutrient intakes of preschool boys alleged to be behavior-responsive to sugar and their peers
27. Dietary characteristics of hyperactive and control boys
28. Overall nutrient intake of preschool hyperactive and normal boys
29. Dietary correlates of hyperactive behavior in children
30. Refined carbohydrate intake, hair cadmium levels, and cognitive functioning in children
31. Plasma amino acids in attention deficit disorder
32. Phenylethylaminergic mechanisms in attention-deficit disorder
33. Nitrogen metabolism in normal and hyperkinetic boys
34. Amino acid supplementation as therapy for attention deficit disorder (ADD)
35. An open trial of l-tyrosine in the treatment of attention deficit disorder, residual type
36. Treatment of attention-deficit disorder with d,l-phenylalanine
37. S-Adenosyl-l-methionine (SAM) in adults with ADHD, RS: Preliminary results from an open trial
38. Amino acid precursors for the treatment of attention-deficit disorder, residual type
39. Effect of tyrosine on attention deficit disorder with hyperactivity
40. L-Tryptophan in hyperactive child syndrome associated with epilepsy: A controlled study
41. Effects of levodopa on attention deficit disorder, residual type
42. Treatment of hyperactive children with d-phenylalanine
43. Enhancement of attention processing by Kantroll in healthy humans: A pilot study
44. Death and liquid protein
45. Tryptophan and carcinogenesis: Review and update on how tryptophan may act
46. Pathogenesis of L-tryptophan eosinophilia-myalgia syndrome
47. Structural characterization of contaminants found in commercial preparations of melatonin: Similarities to case-related compounds from L-tryptophan associated with eosinophilia-myalgia syndrome
48. Eosinophilia myalgia syndrome
49. Diagnostic bias in clinical decision making: An example of L-tryptophan and the diagnosis of eosinophilia-myalgia syndrome
50. Overview and equations predicting plasma concentrations from dietary intake: Metabolic consequences for prostaglandin, leukotriene, and thromboxane production
51. Essential fatty acids as determinants of cytokine immunoneuroendocrine interactions in major depression
52. Potential link between dietary intake of fatty acids and behavior: Pilot exploration of serum lipids in ADHD
53. Overview of omega-3 fatty acids in infant development: Visual, cognitive, and behavioral outcomes
54. Essential fatty acids predict metabolites of serotonin and dopamine in cerebrospinal fluid among healthy control subjects, and early- and late-onset alcoholics
55. Essential fatty acids and maladjusted behavior in children
56. Clinical characteristics and serum essential fatty acid levels in hyperactive children
57. Essential fatty acid metabolism in boys with attention-deficit hyperactivity disorder
58. Relationships between serum free fatty acids and zinc and ADHD
59. The effect of docosahexaenoic acid on aggression in young adults: A placebo-controlled double-blind study
60. Essential fatty acids in major depression
61. Essential fatty acid status and markers of serotonergic neurotransmission in alcoholism and suicide
62. Bipolar disorder - Observational and interventional studies
63. The effects of essential fatty acid supplementation by Efamol in hyperactive children
64. Gamma-linolenic acid for attention-deficit hyperactivity disorder: Placebo-controlled comparison to d-amphetamine
65. Effect of dietary docosahexaenoic acid supplementation on children with ADHD: Preliminary unpublished data
66. Evidence for the involvement of carnitine-dependent long-chain acyltransferases in neuronal triglyceride and phospholipid fatty acid turnover
67. Role of acetyl-l-carnitine in rat brain lipogenesis: Implications for polyunsaturated fatty acid synthesis
68. Fatty acid abnormalities in hemodialysis patients: Effect of l-carnitine administration
69. Double-blind, placebo-controlled study of l-acetylcarnitine for the treatment of hyperactive behavior in Fragile X syndrome
70. Effect of nutritional supplements on attentional-deficit hyperactivity disorder
71. Effect of glyconutritionals on the severity of ADHD
72. Deanol in the treatment of hyperkinetic children
73. Comparison of a tranquillizer and psychic energizer used in treatment of children with behavior disorders
74. The effect of a central nervous system stimulant (deanol) on behavior
75. Deanol and methylphenidate in minimal brain dysfunction
76. Drugs in the management of minimal brain dysfunction
77. Drug therapy in the treatment of minimal brain dysfunction
78. The stimulant effect of 2-dimethylaminoethanol (Deanol) in human volunteer subjects
79. Vitamin and mineral supplements improve the intelligence scores and concentration of six-year-old children
80. Vitamin/mineral supplementation and intelligence
81. Megavitamins for MBD: A placebo-controlled study
82. Effects of megavitamin therapy on children with attention deficit disorders
83. Megavitamins and learning disorders: A controlled double-blind experiment
84. A preliminary study of the effect of pyridoxine administration in a subgroup of hyperkinetic children: A double-blind crossover comparison with methylphenidate
85. The effects of megadoses of selected B complex vitamins on children with hyperkinesis: Controlled studies with long-term follow-up
86. Megavitamins for minimal brain dysfunction: A potentially dangerous therapy
87. Sensory neuropathy from pyridoxine abuse: A new megavitamin syndrome
88. Vitamin B6 in clinical neurology
89. Vitamin neurotoxicity
90. Pyridoxine toxicity to cultured fibroblasts caused by near-ultraviolet light
91. Vitamin B6 toxicity: A new megavitamin syndrome
92. Acute isoniazid intoxication: Reversal of CNS symptoms with large doses of pyridoxine
93. Immunotoxicity of the colour additive caramel colour III: A review on complicated issues in the safety evaluation of a food additive
94. Magnesium and therapeutics
95. Deficiency of certain trace elements in children with hyperactivity
96. Iron treatment in children with ADHD: A preliminary report
97. Randomized study of cognitive effects of iron supplementation in non-anemic iron-deficient girls
98. Evaluation of the effectiveness of gastro-protected proteoferrin in the therapy of sideropenic anemia in childhood
99. Zinc deficiency in attention-deficit/hyperactivity disorder
100. Some effects of prenatal zinc deficiency on behavior of the adult rat
101. Zinc deficiency: Effects on brain and behavior of rats and rhesus monkeys
102. Current status of zinc in health and disease states
103. Zinc deficiency in ADHD
104. Hyperactivity and serum and hair zinc levels in 11-year-old children from the general population
105. Does hair zinc predict amphetamine improvement of ADHD/hyperactivity?
106. Pure white cell aplasia and health food products
107. Magnesium deficiency: Etiology and clinical spectrum
108. Assessment of magnesium levels in children with ADHD
109. The effects of magnesium physiological supplementation on hyperactivity in children with ADHD: Positive response to magnesium oral loading test
110. Stimulant-like effects of magnesium on aggression in mice
111. Preliminary study of traditional Chinese medicine treatment of minimal brain dysfunction: Analysis of 100 cases
112. Clinical and experimental studies on Tiaoshen Liquor for infantile hyperkinetic syndrome
113. Clinical observations and treatment of hyper-kinesia in children by traditional Chinese medicine
114. Urinary 3-methoxy-4-hydroxyphenylglycol sulfate excretion in seventy-three schoolchildren with minimal brain dysfunction
115. St. John's wort for depression - An overview and meta-analysis of randomized clinical trials
116. Physiological basis of hyperkinesis treated with methylphenidate
117. Quantitative analysis of EEG in boys with attention-deficit-hyperactivity disorder: Controlled study with clinical implications
118. Discourse on the development of EEG diagnostics and biofeedback for attention-deficit/hyperactivity disorders
119. Use of biofeedback in the treatment of seizure disorders and hyperactivity
120. Evaluation of the effectiveness of EEG neurofeedback training for ADHD in a clinical setting as measured by changes in TOVA scores, behavior ratings, and WISC-R performance
121. A controlled study of the effects of EEG biofeedback on cognition and behavior of children with attention deficit disorder and learning disabilities
122. Some nontraditional (unconventional and/or innovative) psychosocial treatments for children and adolescents: Critique and proposed screening principles
123. Hypnotherapy: A possible alternative for treating pupils affected with attention, deficit disorder
124. Attention training through breathing control to modify hyperactivity
125. Biofeedback as a treatment for childhood hyperactivity: A critical review of the literature
126. The effects of EMG-assisted relaxation training on the academic performance, locus of control, and self-esteem of hyperactive boys
127. Relaxation training and its relationship to hyperactivity in boys
128. Biofeedback-induced relaxation training and impulsivity, attention to task, and locus of control among hyperactive boys
129. Reduction of hyperactivity using progressive muscle relaxation imagery and autogenic exercises with electromyographic biofeedback
130. Predictors of success in the EMG biofeedback training of hyperactive male children
131. A comparison of biofeedback-assisted relaxation and psychostimulants in treating children with attention deficit disorder with hyperactivity
132. Is group progressive relaxation training as effective with hyperactive children as individual EMG biofeedback?
133. The use of biofeedback techniques with school-aged children exhibiting behavioral and/or learning problems
134. The use of meditation in the treatment of attention deficit disorder with hyperactivity
135. The effects of meditation versus medication in the treatment of attention deficit disorder with hyperactivity
136. Attentional focus of students with hyperactivity during a word-search task
137. The effects of hug machine usage on behavioral organization of children with autism and autism-like characteristics
138. Calming effects of deep touch pressure in patients with autistic disorder, college students, and animals
139. Massage reduces anxiety in child and adolescent psychiatric patients
140. Autistic children's attentiveness and responsivity improve after touch therapy
141. Massage therapy is associated with enhancement of the immune system's cytotoxic capacity
142. Massage therapy reduces anxiety and enhances EEG patter of alertness and math computations
143. Adolescents with attention-deficit hyperactivity disorder benefit from massage therapy
144. Prevention by specific perceptual remediation for vulnerable first-graders: Controlled study and follow-up of lasting effects
145. An analysis of score patterns of children with attention disorders on the sensory integration and praxis tests
146. Vestibular influences on the sympathetic nervous system
147. Do the organs of the labyrinth differentially influence the sympathetic and parasympathetic systems?
148. Hyperkinesis treated by vestibular stimulation: An exploratory study
149. Vestibular and visual rotational stimulation as treatment for attention deficit and hyperactivity
150. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: Clinical description of the first 50 cases
151. An association between recurrent otitis media in infancy and hyperactivity
152. Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive and tic disorders in childhood
153. Hypersensitivity as a cause of dermatologic and vaginal moniliasis resistant to topical therapy
154. Desensitization for monilial hypersensitivity
155. Pediatricians, antibiotics, and office practice
156. A controlled trial of nystatin for the candidiasis hypersensitivity syndrome
157. Role of food allergy in serous otitis media
158. Modulating effect of dietary carbohydrate supplementation on Candida albicans colonization and invasion in a neutropenic mouse model
159. A randomized double-blind trial of nystatin therapy for the candidiasis hypersensitivity syndrome
160. A controlled trial of nystatin for the candidiasis hypersensitivity syndrome
161. A controlled trial of nystatin for the candidiasis hypersensitivity syndrome
162. Attention-deficit hyperactivity disorder and thyroid function
163. Thyroid function in a population of children with ADHD
164. Differences in thyroid function studies in acutely manic adolescents with and without ADHD
165. Thyroid hormone and attention in school-age children with congenital hypothyroidism
166. Thyroid hormones correlate with symptoms of hyperactivity, but not inattention in ADHD
167. Behavioral effects of liothyronine (L-T3) in children with ADHD in the presence and absence of resistance to thyroid hormone
168. Thyroid function and attention deficit hyperactivity disorder
169. Pharmacological and neurochemical investigations of lead-induced hyperactivity
170. Effect of chelation with meso-dimercaptosuccinic acid (DMSA) before and after the appearance of lead-induced neurotoxicity in the rat
171. Lead and hyperactivity: Lead levels among hyperactive children
172. Lead screening in children with ADHD and developmental delay
173. Lead and hyperactivity revisited: An investigation of nondisadvantaged children
174. Deficits in psychologic and classroom performance of children with elevated dentine levels
175. Lead and hyperactivity - Behavioral response to chelation: A pilot study
176. The relationship of hyperactivity to moderately elevated lead levels
177. Biological bases of attention-deficit/hyperactivity disorder: Neuroanatomy, genetics, and pathophysiology
178. Lower serum zinc in major depression in relation to changes in serum acute phase proteins